Biote vs Organigram Global
Biote and Organigram Global are similar in size: $192m and $185m of revenue in their latest fiscal years. Organigram Global grew faster (57.8% against -2.5%). Biote kept more of each dollar of sales as profit: a net margin of 14.1% against -9.6%.
| Latest fiscal year | BioteBTMD, 2025 | Organigram GlobalOGI, 2025 |
|---|---|---|
| Revenue | $192m | $185m |
| Revenue growth | -2.5% | 57.8% |
| Net income | $27.0m | −$17.7m |
| Operating margin | 18.5% | -5.9% |
| Net margin | 14.1% | -9.6% |
| Return on equity | — | -7.4% |
| Free cash flow | $30.2m | −$17.6m |
| Cash | $24.1m | $60.0m |
| Total debt | $103m | $17,951 |
| Debt to equity | — | 0.0% |
| Dividend per share | — | — |
| Dividend yield | 3.6% | — |
| Share buybacks | $3.4m | — |
| Employees | 223 | — |
| Market value | $33.2m | $123m |
| Price vs our value range | Below our value range | — |
| Moat score | 33 (Weak) | — |
| Insider trades, 12 months | 2 buys, 0 sales | 0 buys, 0 sales |